0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Testosterone Hormone Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-33Q5849
Home | Market Reports | Health| Men s Health
Global Testosterone Hormone Drug Market Research Report 2021
BUY CHAPTERS

Testosterone Hormone Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-33Q5849
Report
October 2024
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Testosterone Hormone Drug - Market Size

The global market for Testosterone Hormone Drug was estimated to be worth US$ 1460 million in 2023 and is forecast to a readjusted size of US$ 1274.1 million by 2030 with a CAGR of -1.5% during the forecast period 2024-2030

Testosterone Hormone Drug - Market

Testosterone Hormone Drug - Market

Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Testosterone Hormone Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Testosterone Hormone Drug by region & country, by Type, and by Application.
The Testosterone Hormone Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Hormone Drug.
Market Segmentation

Scope of Testosterone Hormone Drug - Market Report

Report Metric Details
Report Name Testosterone Hormone Drug - Market
Forecasted market size in 2030 US$ 1274.1 million
Forecasted years 2024 - 2030
Segment by Type:
  • Gels
  • Injections
  • Patches
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Viatris, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Testosterone Hormone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Testosterone Hormone Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Testosterone Hormone Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Testosterone Hormone Drug - Market size in 2030?

Ans: The Testosterone Hormone Drug - Market size in 2030 will be US$ 1274.1 million.

Who are the main players in the Testosterone Hormone Drug - Market report?

Ans: The main players in the Testosterone Hormone Drug - Market are AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Viatris, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals

What are the Application segmentation covered in the Testosterone Hormone Drug - Market report?

Ans: The Applications covered in the Testosterone Hormone Drug - Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Testosterone Hormone Drug - Market report?

Ans: The Types covered in the Testosterone Hormone Drug - Market report are Gels, Injections, Patches

1 Market Overview
1.1 Testosterone Hormone Drug Product Introduction
1.2 Global Testosterone Hormone Drug Market Size Forecast
1.2.1 Global Testosterone Hormone Drug Sales Value (2019-2030)
1.2.2 Global Testosterone Hormone Drug Sales Volume (2019-2030)
1.2.3 Global Testosterone Hormone Drug Sales Price (2019-2030)
1.3 Testosterone Hormone Drug Market Trends & Drivers
1.3.1 Testosterone Hormone Drug Industry Trends
1.3.2 Testosterone Hormone Drug Market Drivers & Opportunity
1.3.3 Testosterone Hormone Drug Market Challenges
1.3.4 Testosterone Hormone Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Testosterone Hormone Drug Players Revenue Ranking (2023)
2.2 Global Testosterone Hormone Drug Revenue by Company (2019-2024)
2.3 Global Testosterone Hormone Drug Players Sales Volume Ranking (2023)
2.4 Global Testosterone Hormone Drug Sales Volume by Company Players (2019-2024)
2.5 Global Testosterone Hormone Drug Average Price by Company (2019-2024)
2.6 Key Manufacturers Testosterone Hormone Drug Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Testosterone Hormone Drug Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Testosterone Hormone Drug
2.9 Testosterone Hormone Drug Market Competitive Analysis
2.9.1 Testosterone Hormone Drug Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Testosterone Hormone Drug Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Hormone Drug as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Gels
3.1.2 Injections
3.1.3 Patches
3.2 Global Testosterone Hormone Drug Sales Value by Type
3.2.1 Global Testosterone Hormone Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Testosterone Hormone Drug Sales Value, by Type (2019-2030)
3.2.3 Global Testosterone Hormone Drug Sales Value, by Type (%) (2019-2030)
3.3 Global Testosterone Hormone Drug Sales Volume by Type
3.3.1 Global Testosterone Hormone Drug Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Testosterone Hormone Drug Sales Volume, by Type (2019-2030)
3.3.3 Global Testosterone Hormone Drug Sales Volume, by Type (%) (2019-2030)
3.4 Global Testosterone Hormone Drug Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Testosterone Hormone Drug Sales Value by Application
4.2.1 Global Testosterone Hormone Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Testosterone Hormone Drug Sales Value, by Application (2019-2030)
4.2.3 Global Testosterone Hormone Drug Sales Value, by Application (%) (2019-2030)
4.3 Global Testosterone Hormone Drug Sales Volume by Application
4.3.1 Global Testosterone Hormone Drug Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Testosterone Hormone Drug Sales Volume, by Application (2019-2030)
4.3.3 Global Testosterone Hormone Drug Sales Volume, by Application (%) (2019-2030)
4.4 Global Testosterone Hormone Drug Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Testosterone Hormone Drug Sales Value by Region
5.1.1 Global Testosterone Hormone Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Testosterone Hormone Drug Sales Value by Region (2019-2024)
5.1.3 Global Testosterone Hormone Drug Sales Value by Region (2025-2030)
5.1.4 Global Testosterone Hormone Drug Sales Value by Region (%), (2019-2030)
5.2 Global Testosterone Hormone Drug Sales Volume by Region
5.2.1 Global Testosterone Hormone Drug Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Testosterone Hormone Drug Sales Volume by Region (2019-2024)
5.2.3 Global Testosterone Hormone Drug Sales Volume by Region (2025-2030)
5.2.4 Global Testosterone Hormone Drug Sales Volume by Region (%), (2019-2030)
5.3 Global Testosterone Hormone Drug Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Testosterone Hormone Drug Sales Value, 2019-2030
5.4.2 North America Testosterone Hormone Drug Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Testosterone Hormone Drug Sales Value, 2019-2030
5.5.2 Europe Testosterone Hormone Drug Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Testosterone Hormone Drug Sales Value, 2019-2030
5.6.2 Asia Pacific Testosterone Hormone Drug Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Testosterone Hormone Drug Sales Value, 2019-2030
5.7.2 South America Testosterone Hormone Drug Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Testosterone Hormone Drug Sales Value, 2019-2030
5.8.2 Middle East & Africa Testosterone Hormone Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Testosterone Hormone Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Testosterone Hormone Drug Sales Value
6.2.1 Key Countries/Regions Testosterone Hormone Drug Sales Value, 2019-2030
6.2.2 Key Countries/Regions Testosterone Hormone Drug Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Testosterone Hormone Drug Sales Value, 2019-2030
6.3.2 United States Testosterone Hormone Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Testosterone Hormone Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Testosterone Hormone Drug Sales Value, 2019-2030
6.4.2 Europe Testosterone Hormone Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Testosterone Hormone Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Testosterone Hormone Drug Sales Value, 2019-2030
6.5.2 China Testosterone Hormone Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Testosterone Hormone Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Testosterone Hormone Drug Sales Value, 2019-2030
6.6.2 Japan Testosterone Hormone Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Testosterone Hormone Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Testosterone Hormone Drug Sales Value, 2019-2030
6.7.2 South Korea Testosterone Hormone Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Testosterone Hormone Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Testosterone Hormone Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Testosterone Hormone Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Testosterone Hormone Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Testosterone Hormone Drug Sales Value, 2019-2030
6.9.2 India Testosterone Hormone Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Testosterone Hormone Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Company Information
7.1.2 AbbVie Introduction and Business Overview
7.1.3 AbbVie Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
7.1.4 AbbVie Testosterone Hormone Drug Product Offerings
7.1.5 AbbVie Recent Development
7.2 Endo International
7.2.1 Endo International Company Information
7.2.2 Endo International Introduction and Business Overview
7.2.3 Endo International Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Endo International Testosterone Hormone Drug Product Offerings
7.2.5 Endo International Recent Development
7.3 Eli lilly
7.3.1 Eli lilly Company Information
7.3.2 Eli lilly Introduction and Business Overview
7.3.3 Eli lilly Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Eli lilly Testosterone Hormone Drug Product Offerings
7.3.5 Eli lilly Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Introduction and Business Overview
7.4.3 Pfizer Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Pfizer Testosterone Hormone Drug Product Offerings
7.4.5 Pfizer Recent Development
7.5 Actavis (Allergan)
7.5.1 Actavis (Allergan) Company Information
7.5.2 Actavis (Allergan) Introduction and Business Overview
7.5.3 Actavis (Allergan) Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Actavis (Allergan) Testosterone Hormone Drug Product Offerings
7.5.5 Actavis (Allergan) Recent Development
7.6 Bayer
7.6.1 Bayer Company Information
7.6.2 Bayer Introduction and Business Overview
7.6.3 Bayer Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Bayer Testosterone Hormone Drug Product Offerings
7.6.5 Bayer Recent Development
7.7 Novartis
7.7.1 Novartis Company Information
7.7.2 Novartis Introduction and Business Overview
7.7.3 Novartis Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Novartis Testosterone Hormone Drug Product Offerings
7.7.5 Novartis Recent Development
7.8 Teva
7.8.1 Teva Company Information
7.8.2 Teva Introduction and Business Overview
7.8.3 Teva Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Teva Testosterone Hormone Drug Product Offerings
7.8.5 Teva Recent Development
7.9 Viatris
7.9.1 Viatris Company Information
7.9.2 Viatris Introduction and Business Overview
7.9.3 Viatris Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Viatris Testosterone Hormone Drug Product Offerings
7.9.5 Viatris Recent Development
7.10 Upsher-Smith
7.10.1 Upsher-Smith Company Information
7.10.2 Upsher-Smith Introduction and Business Overview
7.10.3 Upsher-Smith Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Upsher-Smith Testosterone Hormone Drug Product Offerings
7.10.5 Upsher-Smith Recent Development
7.11 Ferring Pharmaceuticals
7.11.1 Ferring Pharmaceuticals Company Information
7.11.2 Ferring Pharmaceuticals Introduction and Business Overview
7.11.3 Ferring Pharmaceuticals Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Ferring Pharmaceuticals Testosterone Hormone Drug Product Offerings
7.11.5 Ferring Pharmaceuticals Recent Development
7.12 Kyowa Kirin
7.12.1 Kyowa Kirin Company Information
7.12.2 Kyowa Kirin Introduction and Business Overview
7.12.3 Kyowa Kirin Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Kyowa Kirin Testosterone Hormone Drug Product Offerings
7.12.5 Kyowa Kirin Recent Development
7.13 Acerus Pharmaceuticals
7.13.1 Acerus Pharmaceuticals Company Information
7.13.2 Acerus Pharmaceuticals Introduction and Business Overview
7.13.3 Acerus Pharmaceuticals Testosterone Hormone Drug Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Acerus Pharmaceuticals Testosterone Hormone Drug Product Offerings
7.13.5 Acerus Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Testosterone Hormone Drug Industrial Chain
8.2 Testosterone Hormone Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Testosterone Hormone Drug Sales Model
8.5.2 Sales Channel
8.5.3 Testosterone Hormone Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Testosterone Hormone Drug Market Trends
    Table 2. Testosterone Hormone Drug Market Drivers & Opportunity
    Table 3. Testosterone Hormone Drug Market Challenges
    Table 4. Testosterone Hormone Drug Market Restraints
    Table 5. Global Testosterone Hormone Drug Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Testosterone Hormone Drug Revenue Market Share by Company (2019-2024)
    Table 7. Global Testosterone Hormone Drug Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Testosterone Hormone Drug Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Testosterone Hormone Drug Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Testosterone Hormone Drug Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Testosterone Hormone Drug Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Testosterone Hormone Drug
    Table 13. Global Testosterone Hormone Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Hormone Drug as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Testosterone Hormone Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Testosterone Hormone Drug Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Testosterone Hormone Drug Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Testosterone Hormone Drug Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Testosterone Hormone Drug Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Testosterone Hormone Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Testosterone Hormone Drug Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Testosterone Hormone Drug Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Testosterone Hormone Drug Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Testosterone Hormone Drug Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Testosterone Hormone Drug Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Testosterone Hormone Drug Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Testosterone Hormone Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Testosterone Hormone Drug Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Testosterone Hormone Drug Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Testosterone Hormone Drug Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Testosterone Hormone Drug Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Testosterone Hormone Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Testosterone Hormone Drug Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Testosterone Hormone Drug Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Testosterone Hormone Drug Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Testosterone Hormone Drug Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Testosterone Hormone Drug Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Testosterone Hormone Drug Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Testosterone Hormone Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Testosterone Hormone Drug Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Testosterone Hormone Drug Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Testosterone Hormone Drug Sales Value by Region (2019-2024) & (%)
    Table 44. Global Testosterone Hormone Drug Sales Value by Region (2025-2030) & (%)
    Table 45. Global Testosterone Hormone Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Testosterone Hormone Drug Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Testosterone Hormone Drug Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Testosterone Hormone Drug Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Testosterone Hormone Drug Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Testosterone Hormone Drug Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Testosterone Hormone Drug Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Testosterone Hormone Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Testosterone Hormone Drug Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Testosterone Hormone Drug Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Testosterone Hormone Drug Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Testosterone Hormone Drug Sales Volume, (2025-2030) & (K Units)
    Table 57. AbbVie Company Information
    Table 58. AbbVie Introduction and Business Overview
    Table 59. AbbVie Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. AbbVie Testosterone Hormone Drug Product Offerings
    Table 61. AbbVie Recent Development
    Table 62. Endo International Company Information
    Table 63. Endo International Introduction and Business Overview
    Table 64. Endo International Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Endo International Testosterone Hormone Drug Product Offerings
    Table 66. Endo International Recent Development
    Table 67. Eli lilly Company Information
    Table 68. Eli lilly Introduction and Business Overview
    Table 69. Eli lilly Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Eli lilly Testosterone Hormone Drug Product Offerings
    Table 71. Eli lilly Recent Development
    Table 72. Pfizer Company Information
    Table 73. Pfizer Introduction and Business Overview
    Table 74. Pfizer Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Pfizer Testosterone Hormone Drug Product Offerings
    Table 76. Pfizer Recent Development
    Table 77. Actavis (Allergan) Company Information
    Table 78. Actavis (Allergan) Introduction and Business Overview
    Table 79. Actavis (Allergan) Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Actavis (Allergan) Testosterone Hormone Drug Product Offerings
    Table 81. Actavis (Allergan) Recent Development
    Table 82. Bayer Company Information
    Table 83. Bayer Introduction and Business Overview
    Table 84. Bayer Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Bayer Testosterone Hormone Drug Product Offerings
    Table 86. Bayer Recent Development
    Table 87. Novartis Company Information
    Table 88. Novartis Introduction and Business Overview
    Table 89. Novartis Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Novartis Testosterone Hormone Drug Product Offerings
    Table 91. Novartis Recent Development
    Table 92. Teva Company Information
    Table 93. Teva Introduction and Business Overview
    Table 94. Teva Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Teva Testosterone Hormone Drug Product Offerings
    Table 96. Teva Recent Development
    Table 97. Viatris Company Information
    Table 98. Viatris Introduction and Business Overview
    Table 99. Viatris Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Viatris Testosterone Hormone Drug Product Offerings
    Table 101. Viatris Recent Development
    Table 102. Upsher-Smith Company Information
    Table 103. Upsher-Smith Introduction and Business Overview
    Table 104. Upsher-Smith Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Upsher-Smith Testosterone Hormone Drug Product Offerings
    Table 106. Upsher-Smith Recent Development
    Table 107. Ferring Pharmaceuticals Company Information
    Table 108. Ferring Pharmaceuticals Introduction and Business Overview
    Table 109. Ferring Pharmaceuticals Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Ferring Pharmaceuticals Testosterone Hormone Drug Product Offerings
    Table 111. Ferring Pharmaceuticals Recent Development
    Table 112. Kyowa Kirin Company Information
    Table 113. Kyowa Kirin Introduction and Business Overview
    Table 114. Kyowa Kirin Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Kyowa Kirin Testosterone Hormone Drug Product Offerings
    Table 116. Kyowa Kirin Recent Development
    Table 117. Acerus Pharmaceuticals Company Information
    Table 118. Acerus Pharmaceuticals Introduction and Business Overview
    Table 119. Acerus Pharmaceuticals Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Acerus Pharmaceuticals Testosterone Hormone Drug Product Offerings
    Table 121. Acerus Pharmaceuticals Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Testosterone Hormone Drug Downstream Customers
    Table 125. Testosterone Hormone Drug Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Testosterone Hormone Drug Product Picture
    Figure 2. Global Testosterone Hormone Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Testosterone Hormone Drug Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Testosterone Hormone Drug Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Testosterone Hormone Drug Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Testosterone Hormone Drug Report Years Considered
    Figure 7. Global Testosterone Hormone Drug Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Testosterone Hormone Drug Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Testosterone Hormone Drug Revenue in 2023
    Figure 10. Testosterone Hormone Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Gels Picture
    Figure 12. Injections Picture
    Figure 13. Patches Picture
    Figure 14. Global Testosterone Hormone Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Testosterone Hormone Drug Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Testosterone Hormone Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Testosterone Hormone Drug Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Testosterone Hormone Drug Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Hospitals
    Figure 20. Product Picture of Clinics
    Figure 21. Product Picture of Others
    Figure 22. Global Testosterone Hormone Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Testosterone Hormone Drug Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Testosterone Hormone Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Testosterone Hormone Drug Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Testosterone Hormone Drug Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Testosterone Hormone Drug Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Testosterone Hormone Drug Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Testosterone Hormone Drug Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Testosterone Hormone Drug Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Testosterone Hormone Drug Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Testosterone Hormone Drug Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Testosterone Hormone Drug Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Testosterone Hormone Drug Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Testosterone Hormone Drug Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Testosterone Hormone Drug Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Testosterone Hormone Drug Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Testosterone Hormone Drug Sales Volume (%), (2019-2030)
    Figure 39. United States Testosterone Hormone Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Testosterone Hormone Drug Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Testosterone Hormone Drug Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Testosterone Hormone Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Testosterone Hormone Drug Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Testosterone Hormone Drug Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Testosterone Hormone Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Testosterone Hormone Drug Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Testosterone Hormone Drug Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Testosterone Hormone Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Testosterone Hormone Drug Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Testosterone Hormone Drug Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Testosterone Hormone Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Testosterone Hormone Drug Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Testosterone Hormone Drug Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Testosterone Hormone Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Testosterone Hormone Drug Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Testosterone Hormone Drug Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Testosterone Hormone Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Testosterone Hormone Drug Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Testosterone Hormone Drug Sales Value by Application (%), 2023 VS 2030
    Figure 60. Testosterone Hormone Drug Industrial Chain
    Figure 61. Testosterone Hormone Drug Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Prostatic Puncture Robot - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-18F14702
Wed Dec 11 00:00:00 UTC 2024

Add to Cart

Add to Cart

Testicular Cancer Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-15I6021
Fri Nov 29 00:00:00 UTC 2024

Add to Cart

Add to Cart